Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research on cancer vaccines reported by scientists at Osaka University
November 18th, 2008
Current study results from the report, 'Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity,' have been published. According to recent research published in the journal Cancer Immunology, Immunotherapy, "Dendritic cell (DC)-based vaccines have been applied clinically in the setting of cancer, but tumor-associated antigens (TAAs) have not yet been enough identified in various cancers. In this study, we investigated whether preventive vaccination with unpulsed DCs or peptide-pulsed DCs could offer anti-tumor effects against MC38 or BL6 liver tumors." "Mice were subcutaneously (s.c.) immunized with...
Source: Cancer Weekly (2008-11-18)
|
